Vaillend C, Aoki Y, Mercuri E, Hendriksen J, Tetorou K, Goyenvalle A
Nat Commun. 2025; 16(1):1298.
PMID: 39900900
PMC: 11790952.
DOI: 10.1038/s41467-025-56644-w.
Parravicini S, Quaranta C, Dainesi M, Berardinelli A
Front Psychol. 2025; 15():1504174.
PMID: 39834775
PMC: 11743717.
DOI: 10.3389/fpsyg.2024.1504174.
Shen F, Zhou H
Front Neurosci. 2024; 18:1459582.
PMID: 39659883
PMC: 11628498.
DOI: 10.3389/fnins.2024.1459582.
Hupen P, Kumar H, Muller D, Swaminathan R, Habel U, Weidler C
Hum Brain Mapp. 2024; 45(15):e70059.
PMID: 39469891
PMC: 11519747.
DOI: 10.1002/hbm.70059.
Blitek M, Phongsavanh X, Goyenvalle A
RSC Med Chem. 2024; 15(9):3017-3025.
PMID: 39309360
PMC: 11411614.
DOI: 10.1039/d4md00394b.
Social and emotional alterations in mice lacking the short dystrophin-gene product, Dp71.
Miranda R, Ceschi L, Le Verger D, Nagapin F, Edeline J, Chaussenot R
Behav Brain Funct. 2024; 20(1):21.
PMID: 39182120
PMC: 11344925.
DOI: 10.1186/s12993-024-00246-x.
Investigation of genotype-phenotype and familial features of Turkish dystrophinopathy patients.
Ozkalayci H, Bora E, Cankaya T, Kocabey M, Zubari N, Yis U
Neurogenetics. 2024; 25(3):201-213.
PMID: 38850354
DOI: 10.1007/s10048-024-00765-9.
Learning, memory and blood-brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140.
Verhaeg M, Adamzek K, van de Vijver D, Putker K, Engelbeen S, Wijnbergen D
Genes Brain Behav. 2024; 23(3):e12895.
PMID: 38837620
PMC: 11151035.
DOI: 10.1111/gbb.12895.
"You Take This Day by Day, Come What May": A Qualitative Study of the Psychosocial Impacts of Living with Duchenne Muscular Dystrophy.
Bever A, Audhya I, Szabo S, Mickle A, Feeny D, Malone D
Adv Ther. 2024; 41(6):2460-2476.
PMID: 38709395
PMC: 11133021.
DOI: 10.1007/s12325-024-02867-0.
Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties: Insights from Clinical Practice.
Geuens S, Goemans N, Lemiere J, Doorenweerd N, Waele L
J Neuromuscul Dis. 2024; 11(4):791-799.
PMID: 38701157
PMC: 11307073.
DOI: 10.3233/JND-230251.
Age-associated sleep spindle characteristics in Duchenne muscular dystrophy.
Simon K, Cadle C, Nakra N, Nagel M, Malerba P
Sleep Adv. 2024; 5(1):zpae015.
PMID: 38525359
PMC: 10960605.
DOI: 10.1093/sleepadvances/zpae015.
Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs.
Crawford A, Hildyard J, Wells D, Piercy R
Wellcome Open Res. 2023; 6:84.
PMID: 37942409
PMC: 10628364.
DOI: 10.12688/wellcomeopenres.16707.2.
Use of the experience sampling method in adolescents with Duchenne muscular dystrophy: a feasibility study.
Lionarons J, Delespaul P, Hellebrekers D, Broen M, Klinkenberg S, Faber C
Eur Child Adolesc Psychiatry. 2023; 33(7):2281-2290.
PMID: 37914846
PMC: 11255059.
DOI: 10.1007/s00787-023-02317-2.
Dystrophin genetic variants and autism.
Passos-Bueno M, Costa C, Zatz M
Discov Ment Health. 2023; 2(1):4.
PMID: 37861890
PMC: 10501027.
DOI: 10.1007/s44192-022-00008-z.
Association between neurodevelopmental impairments and motor function in Duchenne muscular dystrophy.
Thangarajh M, McDermott M, Guglieri M, Griggs R
Ann Clin Transl Neurol. 2023; 10(12):2285-2296.
PMID: 37804000
PMC: 10723228.
DOI: 10.1002/acn3.51914.
Adults living with Duchenne muscular dystrophy: old and new challenges in a cohort of 19 patients in their third to fifth decade.
Gadaleta G, Urbano G, Brusa C, DAlessandro R, Rolle E, Cavallina I
Eur J Neurol. 2023; 31(1):e16060.
PMID: 37724986
PMC: 11235709.
DOI: 10.1111/ene.16060.
Risk of Obstructive Sleep Apnea in Saudi Male Boys with Duchenne Muscular Dystrophy (DMD).
Bamaga A, Alqarni L
Degener Neurol Neuromuscul Dis. 2023; 13:45-53.
PMID: 37601287
PMC: 10439780.
DOI: 10.2147/DNND.S421399.
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies.
Bez Batti Angulski A, Hosny N, Cohen H, Martin A, Hahn D, Bauer J
Front Physiol. 2023; 14:1183101.
PMID: 37435300
PMC: 10330733.
DOI: 10.3389/fphys.2023.1183101.
Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter.
Crawford A, Hornby N, de la Fuente A, Piercy R
BMC Neurosci. 2023; 24(1):21.
PMID: 36932329
PMC: 10024360.
DOI: 10.1186/s12868-023-00788-2.
Neuromuscular disorders and transition from pediatric to adult care in a multidisciplinary perspective: a narrative review of the scientific evidence and current debate.
Accogli G, Ferrante C, Fanizza I, Oliva M, Gallo I, De Rinaldis M
Acta Myol. 2023; 41(4):188-200.
PMID: 36793653
PMC: 9896595.
DOI: 10.36185/2532-1900-083.